Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Prostatic Neoplasms 2Smoking Cessation 1Skin Neoplasms 1Prostate Cancer Prevention 1Melanoma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Cardiotoxicity 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Tobacco Use Cessation Devices 11Varenicline 9Surveys and Questionnaires 9Nicotine Replacement Therapy 7Standard of Care 6Motivational Interviewing 4Methods 4Ethanol 4Smoking Devices 3Preoperative Exercise 3Videotape Recording 2Tomography, X-Ray Computed 2Tobacco Products 2Secondary Prevention 2Nicotine Chewing Gum 2Mindfulness 2Interviews as Topic 2Hematologic Tests 2Focus Groups 2Cognitive Behavioral Therapy 2Carbon Monoxide 2Bupropion 2Aspirin 2thiamine triphosphorate 1sulforaphane 1polyphenon E 1cytisine 1Yoga 1Urinalysis 1Transdermal Patch 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Smoking Cessation × sulforaphane × Clear all
NCT03232138 2024-12-17

Clinical Trial of Lung Cancer Chemoprevention With Sulforaphane in Former Smokers

University of Pittsburgh

Phase 2 Completed
43 enrolled 19 charts
Thoracic

Lung Neoplasms, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡